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Abstract
Background. Formal thought disorder (FTD) and social functioning impairments are core
symptoms of schizophrenia. Although both have been observed for over a century, the strength
of the relationship between FTD and social functioning remains unclear. Furthermore, a variety
of methodological approaches have been used to assess these constructs—whichmay contribute
to inconsistency in reported associations. This meta-analysis aimed to: (a) systematically test the
relationship between FTD and social functioning and (b) determine if the methodology used to
assess FTD and/or social functioning moderates this relationship.
Methods. Following Preferred Reporting Items for Systematic reviews and Meta-analyses
(PRISMA) guidelines, a targeted literature search was conducted on studies examining the
relationship between FTD and social functioning. Correlations were extracted and used to
calculate weighted mean effect sizes using a random effects model.
Results. A total of 1,478 participants across 13 unique studies were included in this meta-
analysis. A small-medium inverse association (r =0.23, p < 0.001) was observed between FTD
and social functioning. Although heterogeneity analyses produced a significant Q-statistic (Q =
52.77, p =<0.001), the relationship between FTD and social functioning was not moderated by
methodology, study quality, demographic variables, or clinical factors.
Conclusions. Findings illustrate a negative association between FTD and social functioning.
Despite differences in the methodological approach used and type of information assessed,
measurement type and clinical factors did not moderate the relationship between FTD and
social functioning. Future studies should explore whether other variables, such as cognitive
processes (e.g., social cognition), may account for variability in associations between these
constructs.
Introduction
Formal thought disorder (FTD) and social functioning deficits are well-documented as hall-
mark features of schizophrenia [1,2]. FTD represents a fundamental disruption in the organi-
zation and maintenance of goal-directed thought; it affects approximately half of those with
schizophrenia [3] and manifests clinically as a core symptom: disorganized speech [4]. Social
functioning deficits (e.g., reduced social contact and poor interpersonal skills) are also prevalent
in schizophrenia and are an important diagnostic criterion [4]. Both FTD and social deficits
persist throughout the disorder and are associated with poor long-term recovery [5–10].
Intuitively, it reasons that those who cannot communicate effectively would also experience
difficulties having meaningful social interactions. To this end, schizophrenia researchers have
considered how FTD and social functioning are related for decades. Cameron [11] hypothesized
that disorganized thought or bizarre speech would be most apparent in social situations and
would ultimately lead to withdrawal in social communication. Marengo and colleagues [12]
described FTD as being “unique to the particular subject,” “deviant with respect to conventional
social norms,” and “frequently hard to understand or empathize with in the context from which
the response arose” (p. 498).
Despite longstanding observation, empirical evidence of the relationship between FTD and
social functioning deficits in schizophrenia is unclear. Across studies, the magnitude of
associations has varied from negligible [13,14] to large [15]. To date, no meta-analysis has
synthesized findings to clarify the relationship between FTD and social functioning. This was
the primary goal of the current meta-analysis. A secondary goal was to identify possible
moderators. In a qualitative review, Roche and colleagues suggested that inconsistencies in
conceptualization and measurement of FTD and social functioning may account for variations
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Conceptualization and measurement of FTD
Bleuler [17] first described FTD as a “loosening of associations” and
made a distinction between disordered thought form
(e.g., derailment and tangentially) and disordered thought content
(e.g., delusions). FTD is a multifaceted construct, comprised pri-
marily of cognitive and linguistic components [1], and is typically
demonstrated behaviorally through speech that is difficult for the
listener to understand due to its poor organization and lack of
semantic cohesion. In the decades since Bleuler’s original descrip-
tion, two primary methods have been implemented to assess FTD:
clinician-rated and trained rater approaches.
Clinician-rated measures of FTD
Clinician-rated measures are the most commonly used approach to
assess FTD [18–20]. Although differences exist between scales,
clinician-rated instruments typically measure FTD using Likert-
style ratings based on disorganized speech observed during an
interview. Notably, some research using clinician-rated scales has
employed a broader conceptualization of FTD, which include a
“pure” FTD item, but also include other cognitive or disorganized
symptoms. For example, the factor-analytically derived Positive
and Negative Syndrome Scale (PANSS [21]) “Disorganized Factor”
consists of items assessing pure FTD (conceptual disorganization),
behavioral disorganization (e.g., odd/unusual mannerism), and
other cognitive symptoms [22]. These factor indices are occasion-
ally used as a proxy for FTD. This may be problematic when
examining how FTD relates to social functioning because these
additional symptoms likely have their own distinct relationships to
social functioning, and thus, may unduly influence reported asso-
ciations with FTD.
Trained rater measures of FTD
Trained rater measures represent another common methodol-
ogy for assessing FTD. With this approach, specific instances
(or behaviors) of FTD are identified, counted, and used to
calculate a ratio-level of FTD. Moreover, these measures typi-
cally involve sophisticated coding systems that allow for differ-
ential weighting of frequency and severity of each instance of
FTD. The verbal samples used to assess FTD are typically based
on speech elicited in response to a behavioral/stimulus task. The
Thought Disorder Index (TDI [23]), for example, assesses FTD
in speech samples based on verbatim responses to the
Rorschach Test [24]. Trained rater measures generally use
standardized scoring systems to assess quantitative and quali-
tative aspects of FTD and have displayed strong psychometric
properties [12,25].
Evidence for potential moderation
It is possible that methodological approach will moderate associ-
ations between FTD and social functioning. Studies that have
examined the degree of convergence between clinician-rated and
trained rater measures only report small to moderate associations
[13,26–28]. Thus, theymay be tapping related, but distinct, aspects
of FTD. In addition, trained rater measures have demonstrated
more sensitivity to subtle levels of FTD, whereas clinician-rated
measures may be designed to capture only gross disturbances
[29–31]. If larger associations are found with trained rater mea-
sures, it could indicate that subtle FTD disturbances impact social
functioning and, thus, further clarify the relationships between
these constructs.
Conceptualization and measurement of social functioning
Establishing a consensus definition of social functioning remains
elusive [32–34]. Global definitions often include other functional
domains, such as the capacity to function in culturally-defined roles
(e.g., worker and student [2]) or include focus on social skills or aspects
of social cognition (e.g., social perception [35,36]; see [37,38]). To
establish a consistent definition for this meta-analysis, we consulted
literature reviews of social functioning measures in schizophrenia
[32,34,39,40]. Although no consensus definition emerged, reference
to interpersonal relationships and social interactions were included
across all definitions and appear to be at the core of social functioning.
Therefore, we decided to narrowly define social functioning as an
individual’s ability to maintain interpersonal relationships and effec-
tively engage in social interactions. Using this definition, three broad
methodological approaches have been used in schizophrenia: self-
report, clinician-rated, and performance-based measures.
Self-report measures of social functioning
A key distinction of self-report measures, compared to other
approaches, is that these measures assess perceived level of social
functioning. Generally, self-report measures of social functioning
are quick to administer and are useful for obtaining information
about the participant’s subjective assessment of their social func-
tioning. However, given the deficits in insight found in schizophre-
nia, self-report measures may not provide an accurate picture of an
individual’s true social functioning.
Clinician-rated measures of social functioning
Clinician-rated measures are designed to provide a clinician’s
impression of patients’ social functioning. Although this approach
still relies on information from patients, clinicians use their exper-
tise to obtain a more nuanced assessment. For example, a patient
may report having five close friends but cannot provide their
names, illustrating discrepancy between subjective and objective
assessments of relationship quality. Notably, clinician-rated mea-
sures assess information about social functioning that requires
clinical judgment regarding appropriateness or adequate involve-
ment in interpersonal relations with regard to societal standards.
Performance-based measures of social functioning
In contrast to other measurement approaches, performance-based
measures provide an objective demonstration of social functioning
via social interaction. With this approach, participants engage in a
simulated social interaction involving another individual
(e.g., examiner) and performance is assessed using standardized
criteria. For example, the Social Skills Performance Assessment
(SSPA [41]), rates participants’ ability to initiate and maintain a
conversation in simulated social situations (e.g., meeting a new
neighbor) and performance is scored on various criteria
(e.g., persistence, engagement, and appropriateness).
Evidence for potential moderation
Measurement typemaymoderate the FTD-social functioning relation-
ship. For example, research has shown that those with FTD underes-
timate the bizarreness of their speech [42]. Thus, smaller associations
between FTD and social functioning may be observed whenmeasured
via self-report compared to the more objective clinician-rated and
performance-based approaches, as individualsmayhave limited aware-
ness of the impact that FTD has on their social interactions.
Additionally, unlike clinician-rated and self-report measures,
performance-based assessments directly test a person’s ability to
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interact socially. Disorganized speech arising from FTDmay have a
greater impact when social functioning is assessed using this mea-
surement approach and could result in larger associations between
FTD and social functioning. If measurement type is found to be a
significant moderator, it could clarify the impact of FTD on social
functioning with regard to subjective perception (i.e., self-report),
adequacy of social functioning (i.e., clinician-rated) or actual social
interaction (i.e., performance-based).
Study aims and hypotheses
The overall aim of this meta-analysis is to clarify the relationship
between FTD and social functioning in schizophrenia. FTD and
social functioning impairments are core features of schizophrenia;
they emerge early and often persist throughout the disorder. Thus, a
better understanding of their relationship could inform whether
there is utility in developing targeted interventions to decrease
FTD’s impact (e.g., through adaptive/compensatory strategies or
cognitive remediation).
As outlined above, inconsistencies in the operational definition
of both FTD and social functioning have contributed to the diffi-
culty in understanding this relationship.We addressed this issue by
utilizing narrow definitions of FTD and social functioning, as it is
critical to first explore how these variables relate when examining
the most fundamental aspects of each construct. The numerous
methodological approaches to measuring FTD and social function-
ing represents another complicating factor in distilling this rela-
tionship. Determining the impact of different measurement
approaches could further clarify the relationship between these
two constructs. Specific aims of this meta-analysis are to:
• Identify the magnitude of the correlation between FTD and
social functioning in schizophrenia, which we hypothesize to be
negative and in the small to medium range.
• Explore whether measurement type moderates the relationship
between FTD and social functioning. Measurement type
includes both FTD (clinician-rated and trained rater) and social
functioning (self-report, clinician-rated, and performance-
based). Study quality, demographic variables (sex and age) and
clinical factors (total symptoms, positive symptoms, and nega-
tive symptoms) were also examined as potential moderators.
Methods
Literature search
The Preferred Reporting Items for Systematic reviews and Meta-
analyses (PRISMA [43]) guidelines were used to ensure quality and
consistency of meta-analytic reporting. The literature search was
executed using three strategies. First, searches were conducted in:
Pubmed, PsycINFO, Web of Science, Medline, Dissertation and
Thesis (Proquest) and EMBASE, covering journal articles, theses/
dissertations, and conference abstracts published up until March
15, 2019. Search terms included a combination of schizophrenia
and terms referencing FTD (thought disorder: thought dis* OR
disorganized speech: dis*speech) and social functioning (social
func* OR quality of life OR interper*). Second, references from
pertinent qualitative review articles [1,44] were examined for addi-
tional references not detected through the initial search. Third,
forward searches of articles directly examining the link between
FTD and social functioning [7,15,45–49] were conducted to find
additional articles.
Inclusion and exclusion criteria for study selection
Studies were included in the meta-analysis when they: (a) were
available in English; (b) included measures of FTD and social
functioning; (c) reported the necessary correlations; and
(d) samples consisted of at least 75% with schizophrenia or schi-
zoaffective diagnoses. Authors were contacted if bivariate correla-
tions were not reported and studies were excluded if correlations
could not be obtained. A study goal was to examine associations
between FTD and social functioning using only the most funda-
mental aspects of these constructs. Therefore, a priori criteria were
established for inclusion as an FTDmeasure. Specifically, measures
had to only assess FTD (e.g., PANSS: Conceptual Disorganization
Item) and no other symptoms. Thus, any factor index that assessed
FTD in combination with other symptoms was ineligible
(e.g., PANSS: Disorganization Factor), unless authors provided
correlations between a single FTD item and social functioning.
To be included as a social functioning measure, more than half of
the itemshad to specifically assess interpersonal relationshipsor social
interactions—consistent with our operational definition—or have
extractable subscales measuring these domains. This resulted in the
exclusion of numerous measures. For example, the Global Assess-
ment of Functioning (GAF) was excluded because it yields a single
rating encompassing multiple domains of functioning (i.e., social
functioning, occupational functioning, and symptom severity). It also
resulted in social cognitive measures (as defined in [38]) being
excluded because, although they assess skills necessary for social
interaction, they do not examine interaction with another person.
Coding
Variables from eligible studies were coded using codebooks devel-
oped from guidelines suggested by Card [50] and Lipsey and
Wilson [51]. Sample-level characteristics of each study were coded,
including the percentage of the sample with schizophrenia or
schizoaffective disorder, sample size, and demographic information
(i.e., average age, sex [percent female], and racial composition,
symptom severity). Measurement type and name for FTD and
social functioning measures were coded for moderator analyses.
Effect-size level coding
For each study, raw effect sizes (e.g., correlation coefficient) repre-
senting the relationship between FTD and social functioning were
extracted.When appropriate, effect sizes were reverse coded so that
a negative association always indicated that greater FTD was asso-
ciated with worse social functioning. Information regarding the
type of comparison captured was also coded (e.g., relationship
between clinician-rated FTD and self-reported social functioning).
If a study included multiple effect sizes that captured the same
type of relationship, effect sizes were averaged and weighted by
sample size to reduce bias and avoid violating the assumption of
independence [50]. Some studies reported multiple effect sizes cap-
turing unique FTD-social functioning relationships. There was no a
priori decision to include one effect size over another; rather, as
recommended by Card [50], all effect sizes were retained to maxi-
mize the number of comparisons that could be made for categorical
moderator analyses. Thus, for the categorical moderator analyses,
multiple effect sizes from the same study were included and treated
as an independent effect size—which is acceptable when interde-
pendent effects sizes are placed in different subgroups [50]. For the
overall meta-analysis, multiple effect sizes from the same study were
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combined so each study contributed only one effect. Data were
coded into Microsoft Excel before being exported to the Statistical
Package for the Social Sciences (SPSS) version 24.0, and finally to
Comprehensive Meta-Analysis, Version 3 (CMA [52]).
Meta-analytic method
Descriptive statistics were calculated using SPSS. Mean overall
effect sizes were then calculated using CMA. A random effects
model was used to account for both within-study and between-
study variability [51]. Up to six different effect sizes could be
calculated from any study (e.g., clinician-rated FTD–self-reported
social functioning, clinician-rated FTD–clinician-rated social func-
tioning). The effect size magnitude was evaluated using Cohen’s
[53] suggestions for interpreting correlation effect sizes: r= 0.10
(small), r = 0.30 (medium), and r=0.50 (large).
Sensitivity analyses and publication bias tests were conducted
for themain analysis. A one-study-removed sensitivity analysis was
conducted in CMA to identify potential outliers by examining
whether the removal of any one effect size from the analysis would
substantially change the overall mean effect size [54]. Studies were
considered for removal if this change was substantial (e.g., a change
from small-medium effect size to a small effect size). Two
approaches were employed to assess for the presence of publication
bias. First, funnel plots were generated for the main analysis and
visually inspected for publication bias. The presence of publication
bias was indicated if the plot was not approximately triangular in
shape or had an asymmetrical distribution around the mean effect
size [54]. Second, publication bias was assessed statistically using
the Egger’s regression test [55]. Egger’s tests suggest that publica-
tion bias is present when the intercept is significant (p< 0.05).
Heterogeneity and moderator analyses
To examine the presence and extent of heterogeneity, information
fromboth theQ-statistic and the I2 indexwas assessed. A significant
Q-statistic (p< 0.05) indicated the presence of heterogeneity
and the I2 index indicated the magnitude of heterogeneity [56].
Moderator analyses were conducted when the Q-statistic was sig-
nificant and the corresponding I2 values were greater than or equal
to 25% [57]. Categorical moderators (e.g., measurement type) were
categorical and assessed using analysis of variance (ANOVA)
analogs provided in CMA and were considered significant when
Qbetween was significant (p< 0.05) and confidence interval
ranges and I2 values were reduced [57]. Continuous moderators
(e.g., symptom severity) were assessed using the meta-regression
function in CMA using a random-effects model; significant beta
weights indicated moderation of the overall effect, and an accom-




Thirteen unique studies were eligible for inclusion in the meta-
analysis1 (see Figure 1 for PRISMA study retrieval flow diagram).
Detailed study characteristics for individual studies are presented in
Table 1, and overall aggregated study descriptive statistics are
presented in Table 2. Across all eligible studies, a total of 1,478
participants were included.
A variety of measures were used to assess FTD and social
functioning across the 13 studies (see Supplementary Tables S1
and S2 for included measures). For FTD measurement, clinician-
ratedmeasures (k=9) were usedmore frequently than trained rater
measures (k=5). For social functioning, clinician-rated measures
were the most commonly used (k=11), followed by performance-
based measures (k=4) and self-report measures (k= 3).
Sensitivity analyses
Visual inspection of the forest plot indicated heterogeneous effect
sizes. The one-study removed analysis and forest plots indicated
that the point estimate of the mean effect size did not change
drastically with the removal of any study. Therefore, all studies
were retained for analyses. Visual examination of funnel plots
depicting standardized effect sizes plotted against standard error
revealed an overall triangular and approximately symmetrical
shape, suggesting that publication bias was not present. The results
of the Egger’s regression test (t(11) = 0.83, p= 0.43) also support the
conclusion that publication bias was not present in this meta-
analytic sample. Forrest and funnel plots available from first author
upon request.
Main analyses
Effect sizes from 13 independent samples were included to examine
the overall relationship between FTD and social functioning (see
Figure 2 for forest plots). Consistent with hypotheses, there was a
significant, negative effect size between FTD and social functioning,
and the magnitude of the effect size was in the small-medium range
(r=0.23, p<0.001, 95%CI [0.33,0.12]), indicating greater levels
of FTD were associated with worse social functioning (Table 3).
Examining the study-level effect sizes, there was a considerable vari-
ability in reported associations, with sample-level r’s ranging from
r=0.56 to r=0.02. Heterogeneity analyses revealed that significant
heterogeneity was present (Q=52.77, p=<0.001), and the extent of
heterogeneity (I2=77.26) was large, according to guidelines suggested
byHuedo-Medina and colleagues [57]. This suggests that results of the
main analyses should be interpretedwith caution, as the large I2 values
indicates the variance is not due to random error and may potentially
be explained by moderation analyses [62].
Moderator analyses
Given that significant heterogeneity was present, moderator ana-
lyses were conducted on FTDmeasurement type, social functioning
measurement type, study quality, demographic variables, and clin-
ical factors (see Table 4).
FTD measurement type
A total of 14 effect sizes were included across clinician-rated (k= 9)
trained rater measure (k=5) subgroups. Results indicated that FTD
measurement type was not a significant moderator,Qbetween = 1.90,
p= 0.168. At the subgroup level, the average effect size for the
clinician-rated measures remained significant, r=0.28 (95% CI
[0.40, 0.14]), p< 0.001. However, the average effect size for
trained rater measures was not significant, r=0.13 (95% CI
[0.31, .07]), p=0.192.
1It should be noted that one data-set came from a large database that encom-
passed the overlapping samples of identified studies [58–60]. The full database was
the most comprehensive record and avoided the issue of sample overlap and thus,
was chosen to be included in the analyses (termed [61]).
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Social functioning measurement type
A total of 17 effect sizes were included in clinician-rated (k=10),
performance-based (k=4), and self-report (k=3) measure sub-
groups. Guidelines suggest a minimum of four effect sizes be
included for each subgroup to obtain clinically meaningful results
[70]; thus, the self-report subgroup results were not interpreted.
Results indicated social functioning measurement type was not a
significant moderator, Qbetween = 1.15, p=0.563. At the subgroup
level, the average effect sizes remained significant and in the small-
medium range, clinician-rated: r=0.21 (95% CI [0.33, 0.08],
p=0.001), and performance-based: r=0.20 (95% CI [0.38,
0.01], p=0.048).
Study quality
Study quality was assessed with the modified Newcastle Ottawa Scale
adapted for cross-sectional studies [71], which rated studies on
sample selection, assessment, and outcome (high quality: k=6; mod-
erate quality: k=7). The impact of study qualitywas examined using a
categorical moderation analysis, and results indicated that study
quality did not significantly moderate this relationship (p>0.05).
Continuous moderators
Five continuous moderators were examined using meta-regression
analyses: age (k=11), sex (as measured by percent female; k=13),
total symptoms (k= 7), positive symptoms (k=9), and negative
symptoms (k=9). Continuous moderators were run in separate
models and none of the continuous moderator Beta weights were
significant (all p’s > 0.05). Based on the data in this report, average
age, sex, and schizophrenia symptoms (total, positive, or negative)
do not moderate the relationship between FTD and social func-
tioning.
Discussion
FTD and social functioning impairments have been considered
central features of schizophrenia since its earliest clinical descrip-
tions [17]. Nonetheless, the reported magnitude of associations
between these variables have ranged considerably across studies.
This is the first time that associations between FTD and social
functioning have been synthesized using meta-analytic methods.
We observed a significant, inverse relationship between FTD and
THOUGHT DISORDER AND SOCIAL FUNCTIONING
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Figure 1. PRISMA study retrieval flow diagram.
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social functioning of small-medium magnitude. Results were not
influenced by measurement type, study quality, demographic vari-
ables, or clinical factors. A significantly large amount of heteroge-
neity was observed, however, suggesting that other variables are
moderating the relationship between FTD and social functioning.
The finding that FTD is inversely associated with social func-
tioning has implications for the daily lives of those with schizo-
phrenia. Individuals who have tangential, incoherent, and illogical
speech tend to have more difficulty forming and maintaining
interpersonal relationships and are less able to effectively engage
in social interactions. The small-medium association observed in
our study is largely consistent with the magnitude of effects
observed when FTD is compared to impairments in other func-
tional domains (e.g., occupational [47,72,73], general community
functioning [74,75]). Thus, FTD appears to be associated with an
underlying aspect of communication that is necessary for social,
occupational, and community functioning.
Although some studies examining FTD and social functioning
have used broader conceptualizations, this meta-analysis focused
on studies employing puremeasures of each construct. As such, our
findings can be interpreted as reflecting the overall association
between the most fundamental aspects of these constructs. Specif-
ically, for FTD, we included studies that measured FTD only and
did not combine measurement of other cognitive domains
(e.g., insight and attention) or behavioral disorganization symp-
toms. Similarly, for social functioning, we included studies that
primarily measured the interpersonal relationships and social
interaction aspects of social functioning. Given that our primary
aim was to clarify the relationship between FTD and social func-
tioning, analyzing the core aspects of these constructs is an impor-
tant feature of this meta-analysis. Thus, our findings indicate that a
small-medium, negative association remains even after removing
potentially confounding domains that are included in broader
conceptualizations of FTD and social functioning.
Because the effect sizes used in the meta-analysis were based on
correlational data, it is not possible to conclude that the presence of
greater levels of FTD cause impairments in social functioning.
However, given the importance of effective communication in
human interaction, it has been postulated that greater FTD leads
to impairments in social functioning [11,12,76]. For example, Grice
[76] has described the “co-operative principle”which proposes that
when people engage in communication, there are certain conver-
sational rules or “maxims” that both parties understand should be
followed to ensure the meaningful exchange of information
(e.g., “be relevant,” “avoid being ambiguous”). Violation of these
maxims would be detrimental to social functioning. For instance, if
an individual has tangential speech, they will likely discuss topics
that are obliquely and ambiguously related to the conversation.
This would run counter to the expectations of the conversational
partner and leave them confused. In this way, those who have
difficulty organizing thoughts and communicating effectively
may be viewed by those around them as having poor interpersonal
skills, making it difficult to build social relationships.
Conversely, albeit less likely, impaired social functioning may
contribute to greater FTD. With limited social interaction, individ-
uals have less opportunity to practice effective communication.
When compared to those with more frequent social interactions,
these individuals may not receive feedback from others and may be
unaware that their speech is difficult to understand. For example, if
an individual with FTD received feedback that it is difficult to follow
their line of thought, they may attempt to reorganize their thoughts
to communicate more efficiently. Perhaps through repeated inter-
actions and subsequent opportunity to practice organizing their
thoughts, they may be able to change their thinking patterns.
Contrary to hypotheses, none of the tested variables (measure-
ment type, study quality, demographic [age and sex], or clinical
variables [total symptoms, positive symptoms, and negative symp-
toms]) moderated relationships between FTD and social function-
ing. This was particularly surprising with measurement type given
how methodological approaches assessing both FTD and social
functioning differed in the type of information gathered. However,
this finding indicates that despite differences in how, for example,
social functioning information is gathered—whether through self-
report, simulated social interaction, or clinical judgment—the asso-
ciation with FTD is similar. Therefore, a clinician or researcher’s
choice of social functioning measurement approach does not
appear to unduly influence the relationship with FTD.
Although FTD measurement type was not a significant moder-
ator, an interesting finding did emerge. When examining only
trained rater measures, the FTD-social functioning association
was reduced and no longer significant. This pattern is consistent
with what has been observed in first-episode psychosis, wherein
Roche and colleagues [16] found that clinician-rated FTD, but not
trained rater FTD, accounted for unique variance in a model
predicting social functioning. One potential explanation for these
finding centers on the context of speech that is used to assess FTD.
Clinician-rated measures assess FTD on speech elicited during
clinical interviews, whereas speech elicited in response to task
Table 1. Overview of sample characteristics.
Sample characteristics Mean (SD) Range k
Mean age 41.0 (7.1) 30.74–56.01 12
Percent female 34.3 (9.2) 24.5–48.6 13
Percent Caucasian 56.9 (23.7) 33.5–95.0 9
Percent African-American 31.6 (23.6) 3.8–66.0 8
Percent diagnosis
Schizophrenia 84.1 (18.7) 57.0–100.0 10
Schizoaffective 13.7 (16.2) 0–43.0 10
Other psychosis 1.3 (4.8) 0–17.5 13
Mean total symptoms 2.18 (0.21) 1.93–2.40 7
Mean positive symptoms 2.37 (0.31) 1.96–2.75 9
Mean negative symptoms 2.16 (0.45) 1.46–3.00 9
Sample type (n, %)
Peer-reviewed 10 (76.9%) – 13
Dissertation 2 (15.4%) 13
Other 1 (7.7%) 13
Mean year 2010 (6.4) 1999–2017 13
Mean sample size (total N = 1,478) 113.7 40–345 13
Location (n, %)
North America 8 (61.5%) – 13
Asia 3 (23.1%) – 13
Australia 1 (7.7%) 13
Europe 1 (7.7%) 13
Abbreviations: Mean total, positive, and negative symptoms, average single item scores on
PANSS equivalent symptom rating measure; SD, standard deviation.
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FTD measure Social Fx measure Association type rTot Pos Neg
Bowie et al. [45] Canada 90 24.5 100 54.4 – – 2.60 2.66 TLC SDS CR-SR 0.110
TLC SLOF-Soc CR-CR 0.180
TLC SSPA CR-PB 0.350
De Sousa et al. [15] England 80 27.5 82.5 95.0 39.3 2.33 2.40 2.00 TLC LSNS CR-SR 0.541
PANSS LSNS CR-SR 0.572
Gilbert [63] United States 40 30.0 100 40 35.6 2.30 – – BPRS: Global FTD GF: Social CR-CR 0.300
SAPS: FTD GF: Social CR-CR 0.350
TDI GF: Social BB-CR 0.120
Luther, Lysaker, and Lysaker [57–59] United States 345 25 95 33.5 45.8 – 2.69 2.27 PANSS QOL:Inter CR-CR 0.001
Moore et al. [64] United States 72 49 100 43 51.2 2.01 1.99 2.16 EII SSPA BB-PB 0.004
Muralidharan et al. [65] United States 248 26 100 52.2 56.0 – 1.96 1.98 TLC SLOF-Soc CR-CR 0.216
TLC SSPA CR-PB 0.139
TLC UPSA-Com CR-PB 0.282
Nienow [66] United States 56 25 100 34 41.5 2.40 2.49 1.46 BPRS AIPSS CR-PB 0.220
Racenstein et al. [47] United States 59 34 100 66 30.74 – – – IPTD-Comp SCOS-SF BB-CR 0.100
IPTD-Prov SCOS-SF BB-CR 0.190
IPTD-Obj SCOS-SF BB-CR 0.170
Smith et al. [67] United States 46 37 100 94 39 – – – SAPS:FTD QOLI-Int CR-CR 0.530
Suttajit et al. [68] Thailand 199 47.7 100 – 37.95 1.93 2.75 1.90 PANSS: PSP CR-CR 0.424
Tan et al. [14] Australia 54 48.1 100 – 43.35 – 2.01 2.01 PANSS QOLI:Soc-sbj CR-SR 0.090
PANSS QOLI:Fam-sbj CR-SR 0.100
PANSS QOLI:Soc-obj CR-CR 0.030
PANSS QOLI:Fam-obj CR-CR 0.040
Ulas et al. [49] Turkey 72 39 100 – 35.7 1.94 – – TLI-DT WHOQOL-Soc BB-CR 0.182
Yalincetin et al. [69] Turkey 117 34 100 – 36.02 2.38 2.42 3.00 TLI-DT PSP BB-CR 0.230
Abbreviations: AIPSS, Assessment of Interpersonal Problem Solving Skills; Association type: first abbreviation corresponds to type of FTDmeasure—BB, behaviorally based; CR, clinician rated; second abbreviation corresponds to type of social functioning
measure—CR, clinician rated; PB, performance-based; SR, self-report; BPRS, Global FTD item on the Brief Psychiatric Rating Scale; %Cauc., % of sample that is Caucasian; EII, Ego Impairment Index; Fam-obj, Objective rating on Family item on QOLI; %Fem,
% of sample that is female; FTD Meas, name of measure(s) used to assess FTD; GF: Social, Global Functioning: Social Scale; IPTD, Index of Positive Thought Disorder—Comp, Comprehension Subtest—Prov, Proverb Subtest—Obj, Object Sorting Subtest;
LSNS, Lubben Social Network Scale; Mean symps., mean symptom; N, number of participants included in the study; Neg, mean for negative symptom item; PANSS, Conceptual Disorganization Item on the Positive and Negative Syndrome Scale; Pos, mean
for positive symptom item; PSP, Personal and Social Performance Scale; QOL:Inter, Interpersonal Subscale of Quality of Life Scale; QOLI: Fam-subj, Subjective rating for Family item onQOLI; QOLI-Inter, Interpersonal domain on the Quality of Life Interview;
QOLI: Soc-subj, Subjective rating for Social itemon theQuality of Life Interview; SAPS-FTD, Global item for the FTD subscale of the Scale for the Assessment of Positive Symptoms; SCOS-SF, Strauss Carpenter Outcomes Scale—Social Functioning subscale;%
SCZ/SZA, % of sample with schizophrenia or schizoaffective diagnosis; SDS, Sheehan Disability Scale—Social subscale; SLOF-Soc, Specific Level of Functioning Scale—Social Functioning; Soc-sbj, Subjective rating for Social item on QOLI; Soc-obj, Objective
rating for Social item on QOLI; Social Fx, name of measure(s) used to assess social functioning; SSPA, Social Skill Performance Assessment; TDI, Thought Disorder Index; TLC, Thought, Language, and Communication Scale; TLI-DT Thought and Language





stimuli, (e.g., Gorham Proverbs Task [77]) serve as the basis for
ratings with trained rater assessment. It has been argued that speech
elicited during behavioral tasks provide limited information about
the nature of language and speech in “real” situations [78]. Itmay be
the case that clinical interviews are more reflective of actual social
interactions compared to most behavioral tasks.
Although restrictive inclusion criteria for social functioning and
FTDmeasures was a strength of this meta-analysis, it also imposed
some limitations. Namely, it resulted in a reduced number of
studies eligible for inclusion. Studies were excluded if they assessed
FTD using disorganized symptom indices or assessed social func-
tioning with measures that predominantly captured information
about other functional domains, symptom severity, or social cog-
nition. Furthermore, an additional methodological approach for
assessing FTD—automated assessment—has emerged over the last
decade [75,79–82]. Although studies employing automated
methods were identified during the literature search [75,83], social
functioning measures in these studies failed to meet inclusion
criteria. Thus, automated assessment was not included as an FTD
methodology in this meta-analysis. Relatedly, our narrow inclusion
criteria likely contributed to restricted range in our constructs of
interest. In turn, this may havemitigated associations between FTD
and social functioning. Another limitation is that the moderating
effect of measurement type may have been detected with a more
sophisticated analysis examining the FTD-social functioning asso-
ciation at specific levels of each measurement type (i.e., clinician-
rated FTD and clinician-rated social functioning versus trained
rater FTD and performance-based social functioning). However,
given the relatively limited number of effect sizes eligible for
inclusion in this study, we did not have a sufficient number of
studies to conduct these analyses [70]. Relatedly, there was large
heterogeneity in the effects sizes included in this study, indicating
that some factor(s) not captured by moderator analyses is
influencing the relationship between FTD and social functioning.
Finally, there were additional limitations in this study that are
common to all meta-analyses (e.g., constraints of the primary
studies) [54].
Despite these limitations, our findings have implications for
future research. Identification of additional moderators could
explain the significant between-study variability of social function-
ing and FTD observed in this analysis and across the literature.
Perhaps underlying cognitive processes could account for some of
the heterogeneity. In particular, social cognition appears to be a
good candidate, as separate lines of research have found social
cognition is linked to both FTD and social functioning. In a
meta-analysis, Fett and colleagues [84] found that 5–23% of the
variance in functional outcome (including social functioning) was
accounted for by social cognition. Medium to large inverse associ-
ations have also been demonstrated between FTD and social cog-
nition [85–88]. It is likely that those with higher levels of social
cognition may overcome the deleterious effects of FTD and have
better social functioning. Conversely, individuals who have high
FTD, accompanied by low social cognition, would suffer a “double
hit” and may have even worse social functioning. Basic cognition,
which has been linked to both FTD [89,90] and functional outcome
[5,91–94] could potentially moderate this relationship in a similar
fashion.
It may also be useful to investigate how context and setting of
speech may affect the FTD-social functioning relationship. Future
research should explore methods for assessing FTD in a person’s
“real-world” environment and test whether this context would
affect the FTD-social functioning relationship. An emerging line
of research in healthy populations has employed passive audio-
recording devices to capture individual’s speech in natural settings
[95,96]. To date, only one study has examined this in
schizophrenia-spectrum populations [97]; however, this
Figure 2. Forest plot of studies included in the meta-analysis examining the relationship between FTD and social functioning (k = 13).
Table 3. Summary of mean effect size for the association between FTD and social functioning.
k ES—r 95% CI z p Q p I2
FTD—social functioning 13 –0.23 [–0.33, –0.12] –3.92 <0.001 52.77 <0.001 77.26
Abbreviations: 95% CI, 95% confidence interval for the mean effect size; ES, sample weighted averaged observed correlation; FTD, formal thought disorder; I2, the extent of between-study
variability; k, number of studies used in the calculation of the mean effect size; Q, test for presence of heterogeneity; Z, z-test for statistical significance of the mean effect size.
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methodology has the potential to provide unique insight into the
impact of FTD on social functioning in people with schizophrenia.
Conclusion
The results of this meta-analysis indicate that a small-medium
relationship exists between social functioning and FTD. Restrictive
inclusion criteria were implemented to allow for the examination of
this association using core aspects of both constructs. Categorical
and continuous moderators (e.g., measurement type) did not
account for the large heterogeneity in this study. Future studies
should explore whether underlying cognitive processes (e.g., social
cognition) or speech settings (e.g., “real” world) could potentially
account for the observed heterogeneity.
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